Last Price$72.7(4.9%)
Market Cap$8,579.9M
LTM Research & Development Expenses (R&D)
$86.7M
YoY Growth
+1.2%
3Y CAGR
+17.1%
5Y CAGR
+8.3%
Stock quality & Intrinsic value
5/10
78.4% undervalued
Albemarle Corporation Research & Development Expenses (R&D)
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development Expenses (R&D) | $41.7M | $46.3M | $62.7M | $67.3M | $60.9M | $58.4M | $77.1M | $78.9M | $82.2M | $88.3M | $102.9M | $80.5M | $84.3M | $70.1M | $58.3M | $59.2M | $54.0M | $72.0M | $85.7M | $86.7M |
Overvalued or undervalued?
Check the intrinsic value for ALB
and see if it's the right time to invest.
Albemarle Corporation (ALB) Research & Development Expenses (R&D) comparison analysis
General
LTM Research & Development Expenses (R&D)
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Albemarle CorporationALB
$86.7M
1.2%
17.1%
8.3%
Median Peer Set
$115.8M
1.4%
0.6%
(0.2%)
International Flavors & Fragrances Inc.IFF
$671.0M
5.5%
2.2%
14.2%
DuPont de Nemours, Inc.DD
$531.0M
4.3%
(4.2%)
(17.7%)
PPG Industries, Inc.PPG
$423.0M
(2.3%)
(1.2%)
(0.4%)
Linde plcLIN
$150.0M
2.7%
1.6%
(4.0%)
LyondellBasell Industries N.V.LYB
$135.0M
3.8%
2.9%
4.0%
Air Products and Chemicals, Inc.APD
$96.5M
(9.7%)
1.1%
5.0%
RPM International Inc.RPM
$92.2M
6.5%
5.9%
5.2%
Ecolab Inc.ECL
$0.0
(100.0%)
(100.0%)
(100.0%)
The Sherwin-Williams CompanySHW
$0.0
(100.0%)
(100.0%)
(100.0%)
Westlake CorporationWLK
$0.0
N/A
N/A
N/A
ALB key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 2,107.5 39.2% | 2,368.5 12.4% | 2,336.2 (1.4%) | 2,467.1 5.6% | 2,005.4 (18.7%) | 2,362.8 17.8% | 2,869.0 21.4% | 2,745.4 (4.3%) | 2,616.4 (4.7%) | 2,445.5 (6.5%) | 3,651.3 49.3% | 2,677.2 (26.7%) | 3,072.0 14.7% | 3,375.0 9.9% | 3,589.4 6.4% | 3,128.9 (12.8%) | 3,328.0 6.4% | 7,320.1 120.0% | 9,617.2 31.4% | 5,377.5 (44.1%) |
| Cost of Goods Sold (COGS) | 1,684.1 | 1,817.7 | 1,713.7 | 1,859.4 | 1,521.5 | 1,616.8 | 1,891.9 | 1,835.4 | 1,755.0 | 1,674.7 | 2,454.5 | 1,706.6 | 1,962.0 | 2,157.7 | 2,331.6 | 2,134.1 | 2,330.0 | 4,245.5 | 8,431.3 | 5,315.0 |
% margin | 423.4 20.1% | 550.8 23.3% | 622.5 26.6% | 607.7 24.6% | 483.9 24.1% | 745.9 31.6% | 977.1 34.1% | 910.0 33.1% | 861.4 32.9% | 770.8 31.5% | 1,196.9 32.8% | 970.6 36.3% | 1,110.0 36.1% | 1,217.3 36.1% | 1,257.8 35.0% | 994.9 31.8% | 998.0 30.0% | 3,074.6 42.0% | 1,185.9 12.3% | 62.5 1.2% |
| Operating Expenses | 259.5 | 284.2 | 307.7 | 361.0 | 285.9 | 324.1 | 389.2 | 392.1 | 245.1 | 443.4 | 615.1 | 460.9 | 522.2 | 516.1 | 591.7 | 489.0 | 495.5 | 596.1 | 934.0 | 1,839.1 |
| Research & Development Expenses (R&D) | 41.7 | 46.3 | 62.7 | 67.3 | 60.9 | 58.4 | 77.1 | 78.9 | 82.2 | 88.3 | 102.9 | 80.5 | 84.3 | 70.1 | 58.3 | 59.2 | 54.0 | 72.0 | 85.7 | 86.7 |
| Selling, General & Administrative Expenses (SG&A) | 219.7 | 237.9 | 245.0 | 255.1 | 225.0 | 265.7 | 312.1 | 313.2 | 162.9 | 355.1 | 512.3 | 380.5 | 437.9 | 446.1 | 533.4 | 429.8 | 441.5 | 524.1 | 919.5 | 618.0 |
% margin | 142.5 6.8% | 145.2 6.1% | 284.8 12.2% | 220.9 9.0% | 186.3 9.3% | 414.8 17.6% | 587.8 20.5% | 406.2 14.8% | 582.9 22.3% | 271.3 11.1% | 442.4 12.1% | 574.6 21.5% | 587.7 19.1% | 911.5 27.0% | 666.1 18.6% | 505.8 16.2% | (100.9) (3.0%) | 2,470.1 33.7% | 251.9 2.6% | (1,776.5) (33.0%) |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 52.9 | 73.1 | 32.5 | 103.8 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 38.2 | 24.6 | 25.5 | 37.6 | 32.8 | 31.6 | 41.4 | 132.7 | 65.2 | 115.4 | 52.4 | 57.7 | 73.1 | 61.5 | 123.0 | 116.1 | 165.6 |
| Pre-tax Income | 149.9 | 133.4 | 277.8 | 183.3 | 160.3 | 392.1 | 550.6 | 374.6 | 544.4 | 213.2 | 358.2 | 515.3 | 446.8 | 794.7 | 563.0 | 373.5 | 133.6 | 2,433.4 | 246.7 | (1,763.8) |
% effective tax rate | 27.6 18.4% | 2.2 1.6% | 55.1 19.8% | (6.5) (3.6%) | (7.0) (4.4%) | 92.7 23.6% | (130.0) (23.6%) | 82.5 22.0% | 136.3 25.0% | 18.5 8.7% | 29.1 8.1% | 96.3 18.7% | 431.8 96.6% | 144.8 18.2% | 88.2 15.7% | 54.4 14.6% | 29.4 22.0% | 390.6 16.1% | 430.3 174.4% | 87.1 (4.9%) |
% margin | 114.9 5.5% | 143.0 6.0% | 229.7 9.8% | 194.2 7.9% | 178.4 8.9% | 323.7 13.7% | 436.3 15.2% | 311.5 11.3% | 413.2 15.8% | 133.3 5.5% | 334.9 9.2% | 643.7 24.0% | 54.9 1.8% | 693.6 20.6% | 533.2 14.9% | 375.8 12.0% | 123.7 3.7% | 2,042.9 27.9% | 1,573.5 16.4% | (1,316.1) (24.5%) |
| EPS | 1.24 | 1.51 | 2.41 | 2.13 | 1.95 | 3.54 | 4.82 | 3.49 | 4.93 | 1.69 | 3.01 | 5.73 | 0.49 | 6.40 | 5.03 | 3.53 | 1.07 | 17.44 | 13.41 | (11.20) |
| Diluted EPS | 1.20 | 1.47 | 2.36 | 2.10 | 1.94 | 3.51 | 4.77 | 3.47 | 4.90 | 1.69 | 3.00 | 5.68 | 0.49 | 6.34 | 5.02 | 3.52 | 1.06 | 17.34 | 13.36 | (11.20) |
% margin | 281.3 13.3% | 468.9 19.8% | 420.4 18.0% | 333.2 13.5% | 285.4 14.2% | 513.2 21.7% | 685.0 23.9% | 506.4 18.4% | 683.4 26.1% | 358.1 14.6% | 652.5 17.9% | 806.6 30.1% | 843.5 27.5% | 950.4 28.2% | 943.3 26.3% | 678.6 21.7% | 875.1 26.3% | 2,867.5 39.2% | 792.8 8.2% | (1,009.6) (18.8%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Albemarle Corporation's Research & Development Expenses (R&D)?
As of today, Albemarle Corporation's last 12-month Research & Development Expenses (R&D) is $86.7M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Albemarle Corporation's Research & Development Expenses (R&D) growth rate?
Over the last year, Albemarle Corporation's Research & Development Expenses (R&D) growth was 1.2%. The average annual Research & Development Expenses (R&D) growth rates for Albemarle Corporation have been 14.7% over the past three years, 8.3% over the past five years.
3) Is Albemarle Corporation's Research & Development Expenses (R&D) growth rate Good?
Over the last year, Albemarle Corporation's Research & Development Expenses (R&D) growth was 1.2%, which is higher than industry growth of (0.8%). It indicates that Albemarle Corporation's Research & Development Expenses (R&D) growth is Bad.